Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Open Label Extension Study of Lanreotide Autogel 120 mg in Patients With Non-functioning Entero-pancreatic Endocrine Tumour

NCT00842348 is registered in ClinicalTrials.gov with Ipsen as lead sponsor.

NCT NCT00842348
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00842348 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Open Label Extension Study of Lanreotide Autogel 120 mg in Patients With Non-functioning Entero-pancreatic Endocrine Tumour
Lead sponsor
Ipsen
Phase
Phase 3
Overall status
Completed
Start date
February 28, 2009
Completion date
December 31, 2015
Enrollment
89 (actual)
Sites
25

Conditions

As the registry lists them; a condition with its own page is linked.

non functioning entero-pancreatic endocrine tumour